CARRARO, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 15.822
EU - Europa 11.417
AS - Asia 5.742
SA - Sud America 900
AF - Africa 110
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 7
Totale 34.027
Nazione #
US - Stati Uniti d'America 15.676
GB - Regno Unito 2.884
CN - Cina 2.632
IE - Irlanda 1.747
SG - Singapore 1.646
RU - Federazione Russa 1.408
UA - Ucraina 1.136
SE - Svezia 969
IT - Italia 940
DE - Germania 910
BR - Brasile 806
FR - Francia 697
HK - Hong Kong 504
KR - Corea 414
FI - Finlandia 412
VN - Vietnam 135
IN - India 124
CA - Canada 77
ES - Italia 54
TR - Turchia 51
JP - Giappone 44
MX - Messico 44
BE - Belgio 40
BD - Bangladesh 37
CZ - Repubblica Ceca 37
PL - Polonia 37
ZA - Sudafrica 28
AR - Argentina 27
AU - Australia 27
NL - Olanda 24
CI - Costa d'Avorio 22
AT - Austria 20
EC - Ecuador 20
PK - Pakistan 20
IQ - Iraq 19
MA - Marocco 17
UZ - Uzbekistan 16
EG - Egitto 14
VE - Venezuela 13
ID - Indonesia 12
LT - Lituania 12
CO - Colombia 11
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
RO - Romania 10
DK - Danimarca 9
KE - Kenya 9
TN - Tunisia 9
CL - Cile 8
JO - Giordania 8
EU - Europa 7
GR - Grecia 7
HU - Ungheria 7
JM - Giamaica 7
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
MY - Malesia 6
PY - Paraguay 6
EE - Estonia 5
IR - Iran 5
LB - Libano 5
LV - Lettonia 5
NO - Norvegia 5
PT - Portogallo 5
AM - Armenia 4
AZ - Azerbaigian 4
BO - Bolivia 4
IL - Israele 4
OM - Oman 4
TW - Taiwan 4
AL - Albania 3
BG - Bulgaria 3
BY - Bielorussia 3
DZ - Algeria 3
LU - Lussemburgo 3
NP - Nepal 3
PH - Filippine 3
BB - Barbados 2
CG - Congo 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
KZ - Kazakistan 2
MD - Moldavia 2
NI - Nicaragua 2
PE - Perù 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CR - Costa Rica 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
Totale 34.012
Città #
Menlo Park 3.035
Southend 2.657
Dallas 2.045
Dublin 1.737
Chandler 1.077
Fairfield 1.009
Jacksonville 921
Singapore 907
Ashburn 780
Beijing 733
Santa Clara 698
Hong Kong 500
Wilmington 470
Ann Arbor 452
Woodbridge 440
Seoul 414
Hefei 388
Houston 382
Seattle 371
Cambridge 366
Nanjing 333
Siena 329
Princeton 296
Moscow 289
Los Angeles 181
Helsinki 169
Boardman 165
New York 146
Munich 134
Nanchang 107
Buffalo 99
San Mateo 83
Milan 77
Shanghai 75
Shenyang 68
Dearborn 67
São Paulo 66
San Diego 65
Kunming 57
Bengaluru 49
Hebei 49
Changsha 48
Tianjin 48
Turku 48
Rome 44
Fremont 43
Jiaxing 43
Council Bluffs 42
London 41
Redondo Beach 40
Ho Chi Minh City 39
Redwood City 39
San Francisco 38
Brussels 36
Dong Ket 36
Düsseldorf 36
The Dalles 36
Florence 35
Norwalk 33
Málaga 32
Jinan 30
Frankfurt am Main 29
Tokyo 29
Toronto 29
Columbus 28
Rio de Janeiro 28
Washington 28
Brooklyn 27
Hangzhou 26
Olomouc 25
Venezia 25
Izmir 23
Ningbo 23
Warsaw 23
Abidjan 22
Atlanta 22
Renton 22
Belo Horizonte 21
Guangzhou 21
Montreal 21
Prato 21
Chicago 20
Hanoi 20
Phoenix 20
Zhengzhou 19
Curitiba 18
Johannesburg 16
Stockholm 16
Chennai 15
Manchester 15
Boston 14
Taizhou 14
Tashkent 14
Denver 13
Amsterdam 12
Changchun 12
Dhaka 12
Lancaster 12
Mexico City 12
Poplar 12
Totale 23.852
Nome #
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 438
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors 356
Adenosine kinase gene expression in human colorectal cancer. 321
Derives substitues en 4 de pyrazolo[3,4-d]pyrimidine et pyrrolo[2,3-d]pyrimidine et utilisations associees 314
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors 305
Novel acylguanidine derivatives targeting smoothened induce antiproliferative and pro-apoptotic effects in chronic myeloid leukemia cells 301
The Shc protein RAI promotes an adaptive cell survival program in hypoxic neuroblastoma cells 300
Different adaptive responses to hypoxia in normal and multiple myeloma endothelial cells 287
Human colorectal cancer: gene expression of purine metabolism 273
Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1α and PI3K/Akt pathway 268
Carborane-Conjugated 2-Quinolinecarboxamide Ligands of the Translocator Protein for Boron Neutron Capture Therapy 259
N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a scaffold for the synthesis of inhibitors of Bcr-Abl 259
Adaptative cellular responses to hypoxia: role of HIF-1 dependent genes in endothelial cell autophagy and survival 257
Administration of interferons and interleukin 2 via the lymphatic route 256
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 254
Design, synthesis, biological activity and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study 252
Analysis of protease-activated receptor-1 and -2 in human scar formation 246
A Ribonuclease Protection Assay-Based Approach for Analysis of Angiogenic Gene Expression in Archival Tissues 244
The adaptor protein p66Shc is a positive regulator in the angiogenic response induced by hypoxic T cells 243
The Shc protein Rai enhances T-cell survival under hypoxia 237
Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma 235
New 4-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 234
Thrombin regulates the expression of pro-angiogenic cytokines via proteolytic activation of protease-activated receptor-1 232
Cell growth inhibition by interferon in hypoxia 230
Neuroglobin in Breast Cancer Cells: Effect of Hypoxia and Oxidative Stress on Protein Level, Localization, and Anti-Apoptotic Function 228
Concentrazioni plasmatiche e tissutali di interferone in pazienti sottoposti a resezione chirurgica per cancro polmonare 228
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs 225
Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks 223
Inhibition of smoothened in breast cancer cells reduces CAXII expression and cell migration 222
The adaptor protein p66shc is a positive regulator in the angiogenic response induced by hypoxic T cells 219
Hypoxia affects dendritic cell survival: Role of the hypoxia-inducible factor-1α and lipopolysaccharide 217
Administration of the interferons via the lymphatic route 217
Carbonic anhydrase XII expression is linked to suppression of Sonic hedgehog ligand expression in triple negative breast cancer cells 216
Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes 214
Alanine kinetics in humans during low-intensity exercise 213
L'ipossia induce l'espressione del recettore attivato da proteasi-1(PAR-1) nelle cellule MDA-MB-231 mediante l'accumulo del fattore indotto dall'ipossia-1alfa 211
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation 209
Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents 209
Role of inflammatory mediators in angiogenesis 205
Pirazolo[3,4-d]pirimidine come nuovi agenti antiproliferativi. Sviluppo di un modello 3D QSAR a bassa dipendenza conformazionale 204
Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells 204
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation 204
Hypoxia and immune surveillance: role of the adaptor protein p66ShcA in negative regulation of T-cell activation and survival ' 202
Pyrazolo[3,4-d]pyrimidines Endowed with Antiproliferative Activity on Ductal Infiltrating Carcinoma Cells 202
Thrombin enhancement of interleukin-1 expression in mononuclear cells: involvement of proteinase-activated receptor-1 201
Hedgehog signalling pathway and Carbonic Anhydrases in Breast cancer cell physiology 201
Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype 200
Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes 195
Hypoxia Shapes Autophagy in LPS-Activated Dendritic Cells 195
Hypoxia induces the expression and release of interleukin 1 receptor antagonist in mitogen-activated mononuclear cells 190
Interleukin 10 production in patients undergoing cardiopulmonary bypass: evidence of inhibition of th-1-type responses 189
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines. 188
The effects of autologous platelet gel on inflammatory cytokine response in human peripheral blood mononuclear cells 187
HIF-1 upregulation by IL-1 contributes to the migratory potential of breast cancer cells 185
Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated caxii 185
Whole body and plasma protein synthesis in exercise and recovery in human subjects 184
Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells 184
Comparative proteomic profiling of normal and breast cancer cells under hypoxic conditions. 183
Urea kinetics in humans at two levels of exercise intensity 183
Regulation of angiogenesis by Th1- and Th2-type cytokines 183
Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells 182
Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases 181
Structure-Based Optimization of Pyrazolo[3,4-d]pyrimidines as Abl Inhibitors and Antiproliferative Agents toward Human Leukemia Cell Lines. 180
‘HIF-1 dependent adaptative responses to hypoxia: pro-survival and pro-apoptotic signaling pathways 180
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma 180
Thrombin inhibits IFN-gamma production in human peripheral blood mononuclear cells by promoting a Th2 profile 179
Interleukin-1β Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1αand NFκB Transcription Factors 179
Pro·angiogenic signaling in neuroblastoma: interplay between HIF-1a and Shc C adaptor protein 176
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1alpha in breast cancer cells 175
Regulation of the hypoxia-inducible factor (HIF)-1α by interleukin-1: implication for breast cancer cell migration in the tumor microenvironment 174
Different expression of cytokines and receptors in bleomycin-sensitive and resistant mice 174
The possible role of T cells and neutrophils in the regulation of tumour angiogenesis 172
Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation 171
Regulation of HMG-CoA reductase expression by hypoxia 171
Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses 170
The thrombin peptide, TP508, enhances cytokine release and activates signaling events 170
Alpha-thrombin reverses differentiation-related changes in expression of P21CIP1/WAF1 in interferon-gamma differentiated monocytic cells 170
Hypoxia enhances the antiviral activity of interferons 169
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1α in MDA-MB-231 breast cancer cells 168
Role of the hypoxic microenvironment in the antitumor activity of tyrosine kinase inhibitors 168
Ozonation of human blood induces a remarkable upregolation of heme oxygenase-1 and heat stress protein-70 167
p66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells 166
Human alpha-Thrombin Stimulates Proliferation of Interferon-gamma Differentiated, Growth-Arrested, U937 Cells, Overcoming Differentiation-Related Changes in Expression of p21CIP1/WAF1 and Cyclin D1 165
Inhibition of Bcr-Abl phosphorylation and induction of apoptosis by pyrazolo[3,4-d] pyrimidines in human leukemia cells 165
Cytokine expression in bleomycin-sensitive and resistant mice 164
Use of interferons in ginecology 164
Interferon (IFN) levels in human pulmonary tumors 163
Role of p52RAI Shc protein in the adaptive response to hypoxia in T cells 163
Quantification of incorporation of [15N]ammonia into plasma amino acids and urea 162
Effect of dichloroacetate on lactate concentration in exercising humans 162
Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach 162
Role of the Hypoxia-Inducible Factor-1alpha and Akt on hypoxia-induced migratory program in dendritic cells 160
Studies for the evaluation of oxygenation and ozonation of blood during extracorporeal circulation 159
The lymphatic route. VIII. Distribution and plasma clearance of recombinant human interleukin-2 after SC administration with albumin in patients 157
Protease-activated receptor-1 and tumor microenvironment: new insights in the inflammation-tumor progression network 156
Interferon levels in human pulmonary tumors are lower than plasma levels 155
Effects of hypoxia on the antiproliferative activity of human interferons 154
p66Shc promotes apoptosis and antagonises mitogenic signaling in T cells. 154
Role of the Hypoxia-Inducible Factor-1alpha and Akt on hypoxia-induced migratory program in dendritic cells 154
Short-term hypoxia activates a migratory program in human monocyte-derived dendritic cells: role of HIF-1α and AKT 153
Totale 20.600
Categoria #
all - tutte 100.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.281 0 0 0 0 161 318 129 436 478 299 277 183
2021/20222.194 152 281 121 237 99 36 83 159 124 214 171 517
2022/20233.909 240 255 589 584 385 789 52 284 444 61 139 87
2023/20242.594 102 65 222 121 96 711 911 124 13 31 28 170
2024/20255.092 125 317 486 227 675 223 99 292 405 161 547 1.535
2025/20266.332 943 1.861 1.631 1.341 556 0 0 0 0 0 0 0
Totale 34.154